Japan, July 14 -- ZOMAGEN BIOSCIENCES LTD has got intellectual property rights for 'NLRP3 MODULATORS.' Other related details are as follows:
Application Number: JP,2025-033957
Category (FI): A61P35/00,A61P35/02,A61P9/10,A61P25/28,A61P25/00,A61P43/00,111,A61K31/55,A61K31/551,C07D495/18,C07D513/18,C07D471/18,C07D491/048,A61K31/439,A61P5/50
Stage: PROBLEM TO BE SOLVED: To provide a modulator compound of NLRP3 (pyrin domain-containing protein 3).SOLUTION: The present invention provides a compound represented by formula (I'), or a pharmaceutically acceptable salt or solvate thereof. As a specific example, sodium ((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4,6,7,8-tetrahydro-5,8-ethanofuro[3,2-c]azepin-2-yl)sulfonyl)amide is presented.SELECTED DRAWING: None (Grant)
Filing Date: March 4, 2025
Publication Date: July 8, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
